<DOC>
	<DOCNO>NCT00655278</DOCNO>
	<brief_summary>This study evaluate safety efficacy T2000 use treat patient moderate severe essential tremor 18 month period .</brief_summary>
	<brief_title>T2000 Essential Tremor - Open Label Continuation</brief_title>
	<detailed_description>Essential tremor ( ET ) common form involuntary shaking relate Parkinson 's disease . The medication currently use treat ET work small proportion patient provide partial improvement symptom . Use current medication also limit side-effects many patient . T2000 medication currently development treatment essential tremor . Although T2000 new medication , belong class medication use many year treatment variety medical condition . In previous study , T2000 appear effective controlling symptom ET patient severe ET major improvement tremor . In patient T2000 well tolerate period 5 month minimal side-effects see would expect medication class . The current study evaluate safety efficacy T2000 patient moderate severe essential tremor . Patients receive dos T2000 begin 600 mg day , follow 800 mg day 1000 mg day . The total duration treatment 18 month . Patient 's tremor neurological examination monitor throughout study .</detailed_description>
	<mesh_term>Tremor</mesh_term>
	<mesh_term>Essential Tremor</mesh_term>
	<criteria>Patients enrol follow completion dose escalation trial ( T20000533 ) Confirmed essential tremor NIH criterion Significant functional activity limitation due ET Patients fail , inadequately treated tolerate alternative treatment ET well treatment na√Øve patient consider decline alternative treatment Patients adequately control without side effect current ET treatment Pregnant patient patient may become pregnant study Patients medical condition may cause tremor , Parkinson 's disease active hyperthyroidism Patients take medication might produce tremor interfere evaluation tremor CNSstimulants betablockers Patients must take medication alter liver metabolism well patient liver disease coagulation disorder Patients seizure disorder Patients history allergy hypersensitivity reaction barbiturate related medication , phenobarbital phenytoin Patient significant general medical clinical laboratory abnormality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Movement Disorder</keyword>
</DOC>